Since the attempt at the allosteric inhibition of KRAS encountered difficulties, research efforts have turned towards the displacement of KRAS from the plasma membrane, the inhibition of downward signaling molecules, and the percussion of the cancer cell’s metabolic repertoire [118]. This evidence concerns the gene KRAS and cancer.